Lakeshore Biopharma Co Ltd Asset Turnover Ratio (LSB), as of fourth quarter 2024, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Lakeshore Biopharma Co Ltd  (NASDAQ: LSB)
 

Lakeshore Biopharma Co Ltd Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the fourth quarter 2024, Lakeshore Biopharma Co Ltd's asset turnover ratio sequentially decreased to 0.37 in the fourth quarter (Mar 31 2024), this is lower than usual.

Within sector 194 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2024 compared to the preceding quarter from 0 to 3504.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LSB Asset Turnover Ratio (Mar 31 2024)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Mar 31 2023)
IV. Quarter
Y / Y Asset Change 124.25 % -14.62 % -14.79 % -14.79 % -0.7 %
Y / Y Revenue Change -19.18 % - - - -
Asset Turnover Ratio (TTM) 0.37 - - - 0.47
LSB's Total Ranking # 3504 # 0 # 0 # 0 # 0
Seq. Asset Change 9.94 % 0.2 % 0 % 103.56 % -58.14 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 195
Healthcare Sector # 545
Overall Market # 3504

Asset Turnover Ratio Statistics
High Average Low
1.29 1.29 1.29
(Mar 31 2024)  




LSB Company Profile • Back to LSB Efficiency Comparisons • Compare LSB Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2024, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2024 Assets at quarter ending Mar 31 2024
Inogen Inc   0.95 $ 321.523  Millions$ 339.960  Millions
National Vision Holdings Inc   0.94 $ 2,106.622  Millions$ 2,232.060  Millions
Ensign Group Inc  0.93 $ 3,852.686  Millions$ 4,130.072  Millions
Bionexus Gene Lab Corp   0.93 $ 9.775  Millions$ 10.481  Millions
Elite Pharmaceuticals Inc   0.93 $ 56.357  Millions$ 60.442  Millions
Sunshine Biopharma Inc   0.93 $ 26.740  Millions$ 28.826  Millions
Embecta Corp   0.93 $ 1,130.400  Millions$ 1,220.125  Millions
Irhythm Holdings Inc   0.93 $ 511.886  Millions$ 553.039  Millions
Tg Therapeutics Inc   0.92 $ 289.333  Millions$ 313.708  Millions
Koru Medical Systems Inc   0.92 $ 29.323  Millions$ 31.828  Millions
Sanara Medtech Inc   0.91 $ 66.262  Millions$ 73.131  Millions
Accuray Incorporated  0.91 $ 429.761  Millions$ 474.446  Millions
National Healthcare Corp  0.90 $ 1,169.157  Millions$ 1,298.257  Millions
Alpha Pro Tech Ltd   0.89 $ 60.446  Millions$ 67.607  Millions
Palvella Therapeutics Inc   0.89 $ 40.927  Millions$ 45.991  Millions
Esperion Therapeutics Inc   0.89 $ 229.740  Millions$ 258.697  Millions
Pediatrix Medical Group Inc   0.89 $ 1,998.733  Millions$ 2,254.956  Millions
Qhslab Inc   0.88 $ 1.545  Millions$ 1.750  Millions
Select Medical Holdings Corp  0.88 $ 6,787.887  Millions$ 7,733.443  Millions
Vapotherm Inc   0.88 $ 70.072  Millions$ 80.053  Millions
Corcept Therapeutics Inc  0.87 $ 523.529  Millions$ 599.025  Millions
Precipio inc   0.86 $ 15.812  Millions$ 18.313  Millions
Inari Medical Inc   0.86 $ 519.698  Millions$ 602.454  Millions
Natera Inc   0.86 $ 1,208.556  Millions$ 1,401.079  Millions
Community Health Systems Inc   0.86 $ 12,522.000  Millions$ 14,548.500  Millions
Lantheus Holdings Inc   0.86 $ 1,364.605  Millions$ 1,585.453  Millions
Amylyx Pharmaceuticals Inc   0.86 $ 398.001  Millions$ 463.771  Millions
Lakeland Industries Inc   0.85 $ 132.297  Millions$ 155.254  Millions
Axogen inc   0.85 $ 163.726  Millions$ 192.403  Millions
Reshape Lifesciences Inc  0.85 $ 8.205  Millions$ 9.643  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.